Skip to main content
Clinical Trials/ACTRN12608000221358
ACTRN12608000221358
Completed
未知

The effect of Community Pharmacy co-ordinated training, feedback and case conferences on the prevalence rate of benzodiazepine and antipsychotic drug use in residential aged care facilities.

The Pharmacy Guild of Australia0 sites24 target enrollmentApril 24, 2008

Overview

Phase
未知
Intervention
Not specified
Conditions
Sedative use in residential aged care facilities. Sedatives are classified for the purposes of this study as antipsychotic, anxiolytic and hypnotic drugs. The majority of anxiolytic and hypnotic dugs are benzodiazepines.
Sponsor
The Pharmacy Guild of Australia
Enrollment
24
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 24, 2008
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Residential Aged Care Facilities \- All residential aged care facilities within the metopolitan areas of Hobart and launceston will be invited to participate in the study. Dementia\-specific residential aged care facilities are exempt.

Exclusion Criteria

  • The psychotropic prevalence rates of the Residenitial Aged Care Facility will be studied as a whole. All residents will be included. Dementia\-specific residential aged care facilities are expempt

Outcomes

Primary Outcomes

Not specified

Similar Trials